wellrank.ai

My compounded semaglutide provider shut down. Where should I move my treatment?

ClaudeswitchingCollected Jul 4, 2026, 12:50 UTC

Verbatim response from Claude

Options for Continuing Semaglutide Treatment

Here are your best options, depending on your situation:

Telehealth Providers with Compounded or Brand-Name GLP-1s

  • Hims & Hers – Wide availability, competitive pricing, offers both compounded and branded options
  • Ro (Body) – Strong medical support, transparent pricing, good app experience
  • LifeMD / Trybe365 – Physician-led, often has good pricing tiers
  • Noom Med – Combines medication with behavioral coaching
  • Found – Focuses on holistic metabolic health alongside medication

Brand-Name Semaglutide (Ozempic/Wegovy)

  • Your primary care doctor or endocrinologist – Can prescribe Wegovy or Ozempic directly
  • Calibrate – Works specifically with branded medications and insurance

Important Considerations

  • Compounded semaglutide availability is changing due to FDA regulations — confirm any new provider is compliant
  • Ask about transition timing to avoid a gap in treatment
  • Check if the new provider accepts your insurance for branded options
  • Request your medical records/dosing history from your previous provider

Quick Recommendation

Ro or Hims & Hers are likely your fastest, most seamless options for continuity with minimal disruption.

Would you like more detail on cost or insurance coverage for any of these?

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.